日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MicroRNA-4516 in extracellular vesicles-derived mesenchymal stem cells suppressed integrin αV-mediated lung fibrosis.

细胞外囊泡衍生的间充质干细胞中的 MicroRNA-4516 抑制了整合素 αV 介导的肺纤维化

Sumiyoshi Issei, Togo Shinsaku, Watanabe Junko, Kaneko Izumi, Uzu Seiji, Yonekura Toshiya, Komatsu Tomoya, Kato Motoyasu, Nakazawa Shun, Motomura Hiroaki, Ochi Yusuke, Kadoya Kotaro, Ihara Hiroaki, Hoshi Kazuaki, Kitamura Hideya, Ogura Takashi, Takahashi Kazuhisa

Tracheal meandering may predict prognosis in idiopathic pleuroparenchymal fibroelastosis: a retrospective observational study

气管迂曲可能预测特发性胸膜肺实质纤维弹性增生症的预后:一项回顾性观察研究

Kato, Motoyasu; Hirakawa, Haruki; Hayakawa, Eri; Hirano, Haruhiko; Tadokoro, Chisato; Kohmaru, Makiko; Akimoto, Takashi; Soma, Soichiro; Kataoka, Shunichi; Arai, Yuta; Nakazawa, Shun; Motomura, Hiroaki; Sueyasu, Takuto; Ochi, Yusuke; Sumiyoshi, Issei; Watanabe, Junko; Kadoya, Kotaro; Ihara, Hiroaki; Togo, Shinsaku; Sasaki, Shinichi; Takahashi, Kazuhisa

Allicin induced AMPK signaling attenuated Smad3 pathway mediated lung fibrosis.

大蒜素诱导的 AMPK 信号传导减弱了 Smad3 通路介导的肺纤维化

Nakazawa Shun, Hou Jia, Kato Motoyasu, Togo Shinsaku, Arai Yuta, Motomura Hiroaki, Kurata Koichi, Sueyasu Takuto, Hirakawa Haruki, Ochi Yusuke, Sumiyoshi Issei, Watanabe Junko, Hoshi Kazuaki, Ihara Hiroaki, Kadoya Kotaro, Takahashi Kazuhisa

Design of buffer property for the new enrichment method of circulating tumor cell based on immunomagnetic-negative separation

基于免疫磁负分离的循环肿瘤细胞富集新方法的缓冲液性能设计

Hoshi, Kazuaki; Hashim, Yasinjan; Togo, Shinsaku; Saiwaki, Shoko; Motomura, Hiroaki; Sumiyoshi, Issei; Nakazawa, Shun; Ochi, Yusuke; Miyoshi, Chieko; Heo, Rihyang; Tabe, Yoko; Abe, Kanae; Urata, Yasuo; Takahashi, Kazuhisa

Antimicrobial susceptibility analysis of isepamicin combination treatments in Mycobacterium abscessus species

异帕米星联合治疗对脓肿分枝杆菌的抗菌药物敏感性分析

Kato, Yukari; Ihara, Hiroaki; Takei, Satomi; Nakamura, Ayako; Fujimoto, Yuichi; Handoh, Tetsuya; Kurokawa, Kana; Arai, Yuta; Shibayama, Kohei; Sumiyoshi, Issei; Ochi, Yusuke; Watanabe, Junko; Hoshi, Kazuaki; Misawa, Shigeki; Togo, Shinsaku; Naito, Toshio; Tabe, Yoko; Miida, Takashi; Takahashi, Kazuhisa

Nintedanib administration after the onset of acute exacerbation of interstitial lung disease in the real world

真实世界中间质性肺病急性加重后使用尼达尼布的治疗

Kato, Motoyasu; Sasaki, Shinichi; Mori, Wataru; Kohmaru, Makiko; Akimoto, Takashi; Hayakawa, Eri; Soma, Soichiro; Arai, Yuta; Matsubara, Naho Sakamoto; Nakazawa, Shun; Sueyasu, Takuto; Hirakawa, Haruki; Motomura, Hiroaki; Sumiyoshi, Issei; Ochi, Yusuke; Watanabe, Junko; Hoshi, Kazuaki; Kadoya, Kotaro; Ihara, Hiroaki; Hou, Jia; Togo, Shinsaku; Takahashi, Kazuhisa

The synergetic effect of sitafloxacin-arbekacin combination in the Mycobacterium abscessus species

西他沙星-阿贝卡星联合用药对脓肿分枝杆菌属的协同作用

Watanabe, Junko; Ihara, Hiroaki; Takei, Satomi; Nakamura, Ayako; Fujimoto, Yuichi; Handoh, Tetsuya; Kurokawa, Kana; Arai, Yuta; Shibayama, Kohei; Sumiyoshi, Issei; Ochi, Yusuke; Okabe, Takahiro; Misawa, Shigeki; Togo, Shinsaku; Naito, Toshio; Tabe, Yoko; Miida, Takashi; Takahashi, Kazuhisa

Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients

新型条件复制腺病毒介导的肺癌患者循环肿瘤细胞高效检测

Ikemoto, Sena; Sakurai, Fuminori; Tokuoka, Sora; Yamashita, Tomoki; Takayama, Kosuke; Hoshi, Kazuaki; Okabe, Takahiro; Sumiyoshi, Issei; Togo, Shinsaku; Takahashi, Kazuhisa; Tachibana, Masashi; Mizuguchi, Hiroyuki

High lymphocyte population-related predictive factors for a long-term response in non-small cell lung cancer patients treated with pemetrexed: a retrospective observational study

高淋巴细胞群体相关预测因子与接受培美曲塞治疗的非小细胞肺癌患者的长期疗效相关:一项回顾性观察研究

Sumiyoshi, Issei; Okabe, Takahiro; Togo, Shinsaku; Takagi, Haruhi; Motomura, Hiroaki; Ochi, Yusuke; Shimada, Naoko; Haraguchi, Mizuki; Shibayama, Rina; Fujimoto, Yuichi; Watanabe, Junko; Iwai, Moe; Kadoya, Kotaro; Iwakami, Shin-Ichiro; Takahashi, Kazuhisa

Clinical Significance of Continuable Treatment with Nintedanib Over 12 Months for Idiopathic Pulmonary Fibrosis in a Real-World Setting

在真实世界中,持续使用尼达尼布治疗特发性肺纤维化超过12个月的临床意义

Kato, Motoyasu; Sasaki, Shinichi; Tateyama, Misa; Arai, Yuta; Motomura, Hiroaki; Sumiyoshi, Issei; Ochi, Yusuke; Watanabe, Junko; Ihara, Hiroaki; Togo, Shinsaku; Takahashi, Kazuhisa